Biologics Continue to Drive Strong Growth in Rheumatoid Arthritis Market

The market for rheumatoid arthritis therapeutics has experienced remarkably strong growth during the past five years due to the introduction of the biological response modifiers (BRMs) to treatment regimens. Total sales of these products are expected to reach approximately $10 billion in 2006, according to a new report from Arrowhead Publishers entitled Rheumatoid Arthritis: Market Trends and R&D Insights. (PRWEB Sep 21, 2006) Trackback URI: http://www.prweb.com/dingpr.php/Q291cC1Db3VwLUluc2UtSG9yci1JbnNlLVplcm8=  Read More »